Skip to content

Bimatoprost Implant

Published: July 26, 2026Updated: August 27, 2026

Durysta is a prescription eye implant that delivers the medication bimatoprost directly into the eye to lower intraocular pressure. It is used to treat open-angle glaucoma and ocular hypertension in patients who need help managing their eye pressure. Unlike daily eye drops, Durysta provides sustained-release treatment over several months, potentially improving medication adherence.

Quick summary

Durysta is an intraocular implant that delivers glaucoma medication continuously for several months to reduce eye pressure in patients with open-angle glaucoma or ocular hypertension.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 27, 2026Editorial policy

Key facts at a glance

RxNorm
2286603
Generic
Durysta
Class
brand-name
Brands
—
Availability
rx
Lactation
unknown
Routes
—
Forms
—
Regions
US, EU, CN, JP
Monitoring
—

This page is for informational purposes only.

Do not use this information to diagnose yourself or to replace a physician's advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication. If you believe you are experiencing a medical emergency, call your local emergency number immediately.

Durysta is indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension who require intraocular pressure reduction.

Durysta contains bimatoprost, a prostaglandin analog that increases aqueous humor outflow from the eye through the trabecular meshwork, thereby reducing intraocular pressure. The biodegradable implant releases medication gradually over approximately 4-6 months.

Durysta is administered as an in-office procedure by a qualified healthcare professional and is not self-administered. Common side effects may include eye redness, eye pain, and conjunctival hyperemia. Patients should have regular follow-up appointments to monitor intraocular pressure and check for potential complications such as implant migration or corneal damage.

Official drug label

WellAlly may earn a referral fee from linked resources at no extra cost to you. Editorial content is never influenced by commercial relationships.

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 27, 2026. · Read our editorial policy